For example, the disulfidptosis-related gene SLC7A11 is proposed to potentially emerge as a new prognostic biomarker for hepatocellular carcinoma (HCC), presenting opportunities for developing personalized cancer immunotherapy strategies (Li et al. 2023). The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.